Sponsor or institution
Clinical trials and research at Bausch & Lomb Incorporated
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Bausch & Lomb Incorporated that are recruiting, at sites in 4 countries (most in United States (2), China (1), Germany (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| BL1107 dosing for drying eye redness: finding the lowest effective amount | Phase 2 | Newport Beach, California | Recruiting | Aug 21, 2026 |
| Artelac Complete MDO vs VISMED Multi eye drops for moderate to severe dry eye disease | — | Freiburg im Breisgau, Baden-Wurttemberg and 11 other locations | Recruiting | May 18, 2026 |
| Evaluation of a new laser treatment for vision correction | — | Zlín, Czech Republic | Recruiting | May 30, 2025 |
| Evaluating Myopia Control Lenses for Children | — | Beijing, Beijing Municipality and 10 other locations | Recruiting | Mar 12, 2024 |
| Safety assessment of the IC-8 Apthera IOL after cataract treatment | — | Dothan, Alabama and 13 other locations | Recruiting | Sep 29, 2023 |
All recruiting trials (5)
-
BL1107 dosing for drying eye redness: finding the lowest effective amount
This trial tests whether different doses of BL1107 can fully reduce conjunctival redness in people with dry eye disease, while keeping participants unaware of the dose they receive.
-
Artelac Complete MDO vs VISMED Multi eye drops for moderate to severe dry eye disease
This trial tests whether Artelac Complete MDO eye drops work as well as VISMED Multi eye drops for people with moderate to severe dry eye disease.
-
Evaluation of a new laser treatment for vision correction
This study is testing a new laser treatment for vision correction to see how well it helps people with nearsightedness and farsightedness after surgery.
-
Evaluating Myopia Control Lenses for Children
This study is testing if Bausch + Lomb Myopia Control Lenses can help children aged 8 to 12 with nearsightedness see better and slow down their vision worsening compared to another type of lens.
-
Safety assessment of the IC-8 Apthera IOL after cataract treatment
This study is testing the safety of the IC-8 Apthera eye lens in people who have had cataract surgery and need treatment for a common complication called posterior capsule opacification.
Quick answers
How many clinical trials run by Bausch & Lomb Incorporated are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), China (1 trial), Germany (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.